Warhound Unveils $200M Plan for Genetically Engineered Military Canines

A significant shift is underway in the U.S. military's approach to canine units, driven by a persistent supply problem that has left defense agencies increasingly dependent on foreign sources. To address this, a new company called Warhound has emerged from stealth mode with a bold proposal: using genetic engineering to create superior working dogs for the military, law enforcement, and emergency response teams. The venture has secured $200 million in funding, valuing the company at $1.2 billion, with support from prominent investors including Sequoia, 8VC, Corner Ventures, and In-Q-Tel, a venture firm with ties to U.S. intelligence agencies.

The urgency behind this initiative stems from a critical gap in the current pipeline of military working dogs. According to the company's launch materials, more than 80% of these animals are currently sourced from Europe, and fewer than half are deemed fit for service upon arrival. Warhound aims to break this reliance by domestically engineering canines with specific traits tailored for demanding missions, such as bomb detection, search operations, and other high-risk tasks that are dangerous for humans or technically challenging for machines.

The project is a collaboration between Ben Lamm of Colossal Biosciences and Palmer Luckey, the founder of Anduril. Lamm recounted meeting Luckey at a conference roughly a year ago, where Luckey expressed concern about the state of military working dogs. This conversation led Lamm to investigate the breeding practices of current canine units. He discovered that many dogs fail to complete training due to inherited health issues, including poor eyesight, hip dysplasia, muscle atrophy, and a high predisposition to cancer.

To overcome these biological limitations, Warhound is utilizing technology from Colossal, which is known for its de-extinction projects like the woolly mammoth. The team has established a biobank containing cell lines from top-performing breeds, specifically the Belgian Malinois and the German Shepherd. The plan involves editing these genes to remove detrimental traits and add those that enhance health, longevity, and physical capabilities such as speed, agility, and olfactory sensitivity. The goal is to produce a new type of dog optimized for military service.

While Colossal handles the biological engineering, Anduril will provide the technological layer that equips the dogs. This includes software and hardware designed to improve situational awareness for both the canines and their handlers. Lamm described the concept as adding capabilities "on top of the dog, not in the dog," such as bulletproof vests embedded with data sensors. These devices would transmit real-time information back to handlers, allowing for better coordination and safety during operations.

The production of these dogs is already in motion. Viagen, another company under Colossal’s umbrella, will handle the cloning process, leveraging its high-success-rate technology currently used in endangered species conservation. Lamm stated that the first batch of dogs is slated for cloning and incubation shortly, with births expected in early 2027. The company aims to have these animals ready for service within two years. Although specific pricing has not been announced, Warhound expects to sell to the Department of Defense, various military branches, police forces, and first responder agencies.

Addressing concerns about the welfare and management of genetically enhanced animals, Lamm noted that each dog will undergo standard military working dog training and be managed by the purchasing agency. To ensure ethical oversight, the company is working with the American Humane Society to certify its training programs. The Society stated that it is pleased to be involved, emphasizing its commitment to science and ethics in ensuring the animals are treated humanely. Additionally, retired Warhound dogs are intended to enter the Society's Military Working Dog Reunification Program to find permanent homes.